GSK to fund startups through venture capital partnership

04/23/2013 | Wall Street Journal, The · Reuters

GlaxoSmithKline and Avalon Ventures, a venture capital firm, will fund up to 10 early-stage drug developers over the next three years. GSK will provide technical support and up to $465 million in initial funding and milestone payments, and will have first rights to buy each startup.

View Full Article in:

Wall Street Journal, The · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN